Need Help? Call 1­-866-­796-­7386
« back to stock screener

  INVA stock: Innoviva Inc

Current Rating
Sell

Previous Rating:

Strong Buy
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$12.85
Market Cap
1.29B
Sector
Health Care
Div. Growth
-100.00%
P/E
24.3
P/B
-
P/S
9.36
Dividend %
8.60%
P/CF
-
P/FCF
25.6
Op. Cash Flow
61K
FCF
0.4
Op. Margin
81.60%
Net Margin
44.60%
ROE
-16.50%
ROI
30.00%
ROA
15.70%
EPS Growth
433.90%
Current Ratio
9.9
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Nephros, Inc. (NEPH) $0.37 - - 19.7M Strong Buy
Eleven Biotherapeutics Inc (EBIO) $2.01 - - 47.5M Strong Buy
Biostar Pharmaceuticals Inc (BSPM) $2.23 - - 6.7M Strong Buy
Encision Inc (ECIA) $0.32 - - 4.7M Strong Buy
Reliv International, Inc (RELV) $5.00 - - 10.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More